162 related articles for article (PubMed ID: 6301365)
1. Ceftriaxone therapy of serious bacterial infections in adults.
Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
Maslow MJ; Levine JF; Pollock AA; Simberkoff MS; Rahal JJ
Antimicrob Agents Chemother; 1982 Jul; 22(1):103-7. PubMed ID: 6289735
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of ceftriaxone.
File TM; Tan JS; Salstrom SJ
Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of ceftriaxone in the pediatric field].
Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone therapy of serious bacterial infections.
Eron LJ; Park CH; Goldenberg RI; Poretz DM
J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ceftriaxone in serious bacterial infections.
Epstein JS; Hasselquist SM; Simon GL
Antimicrob Agents Chemother; 1982 Mar; 21(3):402-6. PubMed ID: 6285809
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone: in vitro studies and clinical evaluation.
Gnann JW; Goetter WE; Elliott AM; Cobbs CG
Antimicrob Agents Chemother; 1982 Jul; 22(1):1-9. PubMed ID: 6289734
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone in the treatment of serious infections, particularly after surgery.
Scully BE; Neu HC
Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
Bradsher RW; Snow RM
Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone (Ro 13-9904) therapy of serious infection.
Bradsher RW
Antimicrob Agents Chemother; 1982 Jul; 22(1):36-42. PubMed ID: 6289739
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
[TBL] [Abstract][Full Text] [Related]
12. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
LeFrock JL; Molavi A; McCloskey RV; Rolston K; Chandrasekar P; Henao L; Smith BR; Kannangara W; Schell RF; Carr BB
Am J Med; 1984 Jul; 77(1):72-8. PubMed ID: 6331163
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone: therapeutic results in various infections and kinetic studies.
Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
[TBL] [Abstract][Full Text] [Related]
14. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
[TBL] [Abstract][Full Text] [Related]
15. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation and perspectives of a new cephalosporin: ceftriaxone].
Auvergnat JC; Armengaud M
Rev Med Interne; 1985 Mar; 6(2):187-92. PubMed ID: 3839091
[TBL] [Abstract][Full Text] [Related]
17. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
Plosker GL; Foster RH; Benfield P
Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of ceftriaxone in pediatric infections].
Ohnuma M; Watanabe A
Jpn J Antibiot; 1984 Nov; 37(11):2015-20. PubMed ID: 6098697
[TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
Antimicrob Agents Chemother; 1983 May; 23(5):731-7. PubMed ID: 6307135
[TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone compared with cefotaxime for serious bacterial infections.
Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
